Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
1.
Horm Behav ; 119: 104647, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31778719

RESUMO

Relatively little is known about the effects of endogenous and exogenous steroid hormones on ecologically relevant behavioral and cognitive phenotypes in women, such as emotion recognition, despite the widespread use of steroid hormone-altering hormonal contraceptives (HCs). Though some previous studies have examined the effect of HC use, estradiol, progesterone, and testosterone on emotion recognition in women, they have been limited by cross-sectional designs, small sample sizes (total n < 100), and compromised statistical power to detect significant effects. Using data from two test sessions in a large sample of naturally cycling women (NC; n = 192) and women on HCs (n = 203), we found no group differences in emotion recognition; further, the lack of group differences in emotion recognition was not modulated by item difficulty or emotional valence. Among NC women who provided saliva samples across two sessions that were assayed for estradiol and progesterone concentrations, we found no compelling evidence across models that between-subject differences and within-subject fluctuations in these ovarian hormones predicted emotion recognition accuracy, with the exception that between-subjects estradiol negatively predicted emotion recognition for emotions of neutral valence (p = .042). Among HC women who provided saliva samples across two sessions that were assayed for testosterone, we found no compelling evidence that between-subjects differences and within-subject fluctuations in testosterone predicted emotion recognition accuracy. Overall, our analyses provide little support for the idea that circulating endogenous or exogenous ovarian hormones influence emotion recognition in women.


Assuntos
Anticoncepcionais Orais Hormonais/farmacologia , Inteligência Emocional/efeitos dos fármacos , Hormônios Esteroides Gonadais/metabolismo , Reconhecimento Psicológico/efeitos dos fármacos , Adulto , Estudos Transversais , Inteligência Emocional/fisiologia , Emoções , Estradiol/análise , Estradiol/metabolismo , Feminino , Hormônios Esteroides Gonadais/análise , Humanos , Ovário/efeitos dos fármacos , Ovário/metabolismo , Progesterona/análise , Progesterona/metabolismo , Reconhecimento Psicológico/fisiologia , Saliva/química , Saliva/metabolismo , Testosterona/análise , Testosterona/metabolismo , Adulto Jovem
2.
Psychoneuroendocrinology ; 99: 66-71, 2019 01.
Artigo em Inglês | MEDLINE | ID: mdl-30189345

RESUMO

Adverse childhood experience such as neglect or abuse can lead to long-term deficits in emotion processing abilities. Animal studies indicate that oxytocin production and/or sensitivity are influenced by variation in early nurturing experiences. The goal of this study was to test whether emotion recognition abilities and empathy might be improved via intranasal oxytocin administration in adults with a history of childhood maltreatment. We assessed a total of 80 healthy participants, half with and half without a history of childhood adversity. Participants performed the Reading the Mind in the Eyes Test (RMET) and an emotion recognition task under 24 IU intranasal oxytocin and placebo, using a double-blind crossover study design. In the first of two sessions, both groups profited equally form oxytocin administration and showed greater accuracy under oxytocin compared to placebo in the RMET (p = .049). In the emotion recognition task, only the early adversity group benefited significantly from oxytocin administration in the first session (p = .035), mainly due to more accurate recognition of angry and fearful facial expression. Our findings show that emotion processing abilities might be improved via oxytocin administration in adults reporting adverse childhood experiences.


Assuntos
Inteligência Emocional/efeitos dos fármacos , Ocitocina/fisiologia , Administração Intranasal , Adulto , Experiências Adversas da Infância , Estudos Cross-Over , Método Duplo-Cego , Emoções/fisiologia , Expressão Facial , Reconhecimento Facial/efeitos dos fármacos , Feminino , Voluntários Saudáveis , Humanos , Masculino , Pessoa de Meia-Idade , Ocitocina/administração & dosagem , Comportamento Social , Percepção Social , Teoria da Mente/efeitos dos fármacos
3.
Psychoneuroendocrinology ; 99: 87-96, 2019 01.
Artigo em Inglês | MEDLINE | ID: mdl-30216766

RESUMO

The dot probe task implicitly cues attention via emotional information, an effect which is especially pronounced for threat-related cues. However, several questions remain unexplored. The first one is whether chemosignals like the androgen-derivative androstadienone can influence such attentional biases. Second, few studies have addressed sex differences regarding attentional biases. Finally, the neural correlates of these potential behavioral effects based on functional magnetic resonance imaging (fMRI) are not known. In two experiments we aimed to answer these questions. A total of 159 healthy individuals (58 oral-contraceptive-users, 42 luteal women, 59 men) were tested. In experiment 1 (behavioral study) we examined attentional biases behaviorally, while in experiment 2 (fMRI study) the dot probe task was complemented by fMRI. Our results provide robust evidence that in healthy participants fearful but not angry or happy faces lead to a strong general attentional bias. Elucidating the neural basis of this effects points to an early processing advantage in bilateral thalamus for valid compared to invalid cued fear. However, this finding was limited to those participants with the strongest attentional biases and was not linked to behavioral measures. Furthermore, no consistent sex or group differences existed neither did the putative human chemosignal androstadienone reliably modulate attentional biases or change neural processing.


Assuntos
Androstadienos/farmacologia , Viés de Atenção/efeitos dos fármacos , Viés de Atenção/fisiologia , Inteligência Emocional/efeitos dos fármacos , Adulto , Atenção , Sinais (Psicologia) , Inteligência Emocional/fisiologia , Emoções/efeitos dos fármacos , Expressão Facial , Reconhecimento Facial/efeitos dos fármacos , Reconhecimento Facial/fisiologia , Feminino , Humanos , Imageamento por Ressonância Magnética/métodos , Masculino , Odorantes , Percepção Olfatória/fisiologia , Fatores Sexuais , Adulto Jovem
4.
Seizure ; 60: 96-104, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-29933178

RESUMO

PURPOSE: This study aimed to examine Theory of Mind (ToM) and social competence in children and adolescents with genetic generalised epilepsy (GGE), and explore how they relate to neurocognitive and epilepsy variables. METHODS: Twenty-two children and adolescents with GGE (8-16 years old) and 22 typically developing controls completed two behavioural tasks (faux-pas, strange stories) assessing cognitive and affective ToM, and a battery of standardised neuropsychological tests. Parents completed questionnaires assessing ToM and social competence. Neurologists completed the Global Assessment Severity of Epilepsy (GASE) scale to measure of epilepsy severity. RESULTS: Children and adolescents with GGE were impaired in both cognitive and affective ToM, and had reduced social competence compared to controls, which was not attributable to low intellectual functioning or impaired executive skills (working memory, inhibition). Lower ToM correlated with reduced social competence in children and adolescents with GGE. Clinical variables identified included: (i) higher daily dosage of valproate, which was correlated with reduced affective ToM, (ii) higher daily dosages of ethosuximide and lamotrigine, which were correlated with reduced social competence, and (iii) overall epilepsy severity on the GASE, which was correlated with reduced social competence. CONCLUSIONS: Our study revealed cognitive and affective ToM impairments in children and adolescents with GGE, which correlated with everyday social problems. Moreover, higher dosages of commonly prescribed anti-epileptic drugs and overall epilepsy severity were related to ToM impairments and social competence problems. Although preliminary, these findings provide critical information for detection and screening procedures for social difficulties in children and adolescents with GGE, which are currently lacking.


Assuntos
Epilepsia Generalizada/psicologia , Habilidades Sociais , Teoria da Mente , Adolescente , Afeto/efeitos dos fármacos , Anticonvulsivantes/efeitos adversos , Anticonvulsivantes/uso terapêutico , Criança , Cognição/efeitos dos fármacos , Estudos Transversais , Inteligência Emocional/efeitos dos fármacos , Epilepsia Generalizada/tratamento farmacológico , Função Executiva/efeitos dos fármacos , Feminino , Humanos , Masculino , Testes Neuropsicológicos , Índice de Gravidade de Doença , Teoria da Mente/efeitos dos fármacos
5.
Rev Neurol ; 66(11): 361-367, 2018 Jun 01.
Artigo em Espanhol | MEDLINE | ID: mdl-29790568

RESUMO

INTRODUCTION: Epilepsy is accompanied by cognitive disorders, frequently aggravated by the use of antiepileptic drugs, which can affect social empathy. AIM: To analyse the impact of treatment with eslicarbazepine acetate (ESL) on social cognition and prefrontal cognitive functions in adults with focal epilepsy. PATIENTS AND METHODS: We conducted a prospective single-centre study with patients aged between 18 and 65 years with focal seizures treated with ESL. The patients were evaluated in their baseline visit and at six months after starting ESL treatment by means of tasks designed for theory of mind, executive and attentional functions, auditory-verbal memory, quality of life, and anxiety and depression. RESULTS: Forty-one patients were treated with ESL, and 30 completed the follow-up. A significant improvement was observed in the theory of mind tasks. In the analysis stratified by sex, the men showed greater improvement. A cognitive improvement was observed in the Wisconsin Card Sorting Test, Symbol Digit, Backward Digit Span and Stroop tests. No differences were found in the Quality of Life in Epilepsy-31 Inventory or in the Hospital Anxiety and Depression Scale. These results were independent of the reduction in the number of seizures and the ESL dosage. CONCLUSION: Treatment with ESL could improve some aspects of theory of mind in patients with epilepsy, especially in men and independently of the control of seizures, with no changes in quality of life, anxiety or depression.


TITLE: Cognicion social y funciones cognitivas en pacientes con epilepsia tratados con acetato de eslicarbacepina.Introduccion. La epilepsia se acompaña de alteraciones cognitivas, frecuentemente agravadas por el uso de farmacos antiepilepticos, que pueden afectar a la empatia social. Objetivo. Analizar el impacto del tratamiento con acetato de eslicarbacepina (ESL) en la cognicion social y las funciones cognitivas prefrontales en adultos con epilepsia focal. Pacientes y metodos. Estudio prospectivo y unicentrico realizado en pacientes de 18 a 65 años con crisis focales, tratados con ESL. Los pacientes fueron evaluados en la visita basal y a los seis meses tras iniciar ESL mediante tareas para la teoria de la mente, funciones ejecutivas y atencionales, memoria audioverbal, calidad de vida, y ansiedad y depresion. Resultados. Cuarenta y un pacientes fueron tratados con ESL y 30 completaron el seguimiento. Se observo una mejoria significativa en las tareas de teoria de la mente. En el analisis estratificado por sexo, los hombres mejoraron mas. Se observo una mejoria cognitiva en las pruebas Wisconsin Card Sorting Test, Symbol Digit, Backward Digit Span y test de Stroop. No hubo diferencias en el cuestionario Quality of Life in Epilepsy-31 Inventory ni en la escala de depresion y ansiedad hospitalaria (HADS). Estos resultados fueron independientes de la reduccion del numero de crisis y de la dosis de ESL. Conclusion. El tratamiento con ESL podria mejorar algunos aspectos de la teoria de la mente en pacientes con epilepsia, especialmente en hombres e independientemente del control de las crisis, sin cambios en la calidad de vida, ansiedad o depresion.


Assuntos
Anticonvulsivantes/uso terapêutico , Cognição/efeitos dos fármacos , Dibenzazepinas/uso terapêutico , Inteligência Emocional/efeitos dos fármacos , Epilepsias Parciais/tratamento farmacológico , Adulto , Anticonvulsivantes/administração & dosagem , Anticonvulsivantes/efeitos adversos , Ansiedade/etiologia , Depressão/etiologia , Dibenzazepinas/administração & dosagem , Dibenzazepinas/efeitos adversos , Relação Dose-Resposta a Droga , Epilepsias Parciais/psicologia , Função Executiva/efeitos dos fármacos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Testes Neuropsicológicos , Estudos Prospectivos , Qualidade de Vida , Teoria da Mente/efeitos dos fármacos , Aprendizagem Verbal/efeitos dos fármacos
6.
Acta Paediatr ; 107(8): 1370-1378, 2018 08.
Artigo em Inglês | MEDLINE | ID: mdl-29469926

RESUMO

AIM: To test the effect of folic acid supplements taken throughout pregnancy on children's psychosocial development. METHOD: A randomised controlled trial of folic acid supplementation in pregnancy, with parental rating using the Resiliency Attitudes and Skills Profile (RASP), the Strengths and Difficulties Questionnaire (SDQ) and the Trait Emotional Intelligence Questionnaire Child Short Form (TEIQue-CSF). Children aged 6-7 whose mothers received folic acid throughout pregnancy (n = 22) were compared to those whose mothers only received it during the first trimester (n = 17). RESULTS: Children whose mothers received the full-term supplement scored significantly higher on emotional intelligence and resilience. Hierarchical multiple regression analysis identified folate level at 36th gestational week as an important predictor of emotional intelligence (EI) and resilience. CONCLUSION: Although conclusions must be drawn with caution, this research presents a number of potential implications, the main one being a proposed policy recommendation for women to take folic acid for the duration of pregnancy rather than stopping at the end of the first trimester. The second is the potential for future research to explore the possible psychological and social development benefits and in line with this to try and identify the explanatory mechanism involved.


Assuntos
Inteligência Emocional/efeitos dos fármacos , Desenvolvimento Fetal/efeitos dos fármacos , Ácido Fólico/administração & dosagem , Saúde do Lactente , Cuidado Pré-Natal/métodos , Suplementos Nutricionais , Feminino , Seguimentos , Humanos , Modelos Logísticos , Masculino , Micronutrientes/administração & dosagem , Análise Multivariada , Gravidez , Valores de Referência , Resiliência Psicológica/efeitos dos fármacos
7.
Horm Behav ; 99: 25-34, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-29408521

RESUMO

Oxytocin is a neuropeptide that plays a key role in social processing and there are several studies suggesting that intranasally administered oxytocin may enhance social cognitive abilities and visual attention in healthy and clinical groups. However, there are very few studies to date that have investigated the potential benefits of intranasal oxytocin (iOT) on older adults' social cognitive abilities. This is a surprising omission, because relative to their younger counterparts, older adults also exhibit a range of social cognitive difficulties and also show differences in the way they visually attend to social information. Therefore, we tested the effect of iOT (24 IU) versus a placebo spray on 59 older and 61 younger adults' social cognitive abilities and visual attention using a double-blind placebo-controlled within-groups design. While iOT provided no overall age-related benefit on social cognitive abilities, the key finding to emerge was that iOT improved ToM ability in both age-groups when the task had minimal contextual information, but not when the task had enriched contextual information. Interestingly, iOT had gender specific effects during a ToM task with minimal context. For males in both age-groups, iOT reduced gazing to the social aspects of the scenes (i.e., faces & bodies), and for females, iOT eliminated age differences in gaze patterns that were observed in the placebo condition. These effects on eye-gaze were not observed in a very similar ToM task that included more enriched contextual information. Overall, these findings highlight the interactive nature of iOT with task related factors (e.g., context), and are discussed in relation to the social salience hypothesis of oxytocin.


Assuntos
Envelhecimento/psicologia , Inteligência Emocional/efeitos dos fármacos , Ocitocina/administração & dosagem , Comportamento Social , Administração Intranasal , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Envelhecimento/efeitos dos fármacos , Atenção/efeitos dos fármacos , Cognição/efeitos dos fármacos , Método Duplo-Cego , Feminino , Fixação Ocular/efeitos dos fármacos , Humanos , Masculino , Percepção Visual/efeitos dos fármacos , Adulto Jovem
8.
Hum Psychopharmacol ; 32(6)2017 11.
Artigo em Inglês | MEDLINE | ID: mdl-28913946

RESUMO

OBJECTIVES: To explore whether facial emotion recognition (FER), impaired in both schizophrenia and alcohol and substance use disorders (AUDs/SUDs), is additionally compromised among comorbid subjects, also considering the role of catechol-O-methyltransferase (COMT) Val158Met. METHODS: We conducted a cross-sectional study, randomly recruiting 67 subjects with a DSM-IV-TR diagnosis of schizophrenia, and rigorously assessing AUDs/SUDs and COMT Val158Met polymorphism. FER was assessed using the Ekman 60 Faces Test- EK-60F. RESULTS: As a whole, the sample scored significantly lower than normative data on EK-60F. However, subjects with comorbid AUDs/SUDs did not perform worse on EK-60F than those without, who had a better performance on EK-60F if they carried the COMT Val/Met variant. CONCLUSIONS: This study is the first to date examining the impact of AUDs/SUDs and COMT variants on FER in an epidemiologically representative sample of subjects with schizophrenia. Our findings do not suggest an additional impairment from comorbid AUDs/SUDs on FER among subjects with schizophrenia, whilst COMT Val158Met, though based on a limited sample, might have a role just among those without AUDs/SUDs. Based on our results, additional research is needed also exploring differential roles of various substances.


Assuntos
Catecol O-Metiltransferase/genética , Reconhecimento Facial , Esquizofrenia/complicações , Esquizofrenia/genética , Transtornos Relacionados ao Uso de Substâncias/complicações , Transtornos Relacionados ao Uso de Substâncias/genética , Adulto , Comorbidade , Estudos Transversais , Inteligência Emocional/efeitos dos fármacos , Inteligência Emocional/genética , Reconhecimento Facial/efeitos dos fármacos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Testes Neuropsicológicos , Polimorfismo de Nucleotídeo Único , Esquizofrenia/tratamento farmacológico , Esquizofrenia/epidemiologia , Psicologia do Esquizofrênico , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Transtornos Relacionados ao Uso de Substâncias/psicologia
9.
Horm Behav ; 90: 136-140, 2017 04.
Artigo em Inglês | MEDLINE | ID: mdl-28322748

RESUMO

The social saliency account proposes that oxytocin (OT) plays a major role in modulating attentional shifts toward social cues at early stages of processing. We investigated how OT promotes early attention toward nonsocial and social stimuli and explored differences between in-group- and out-group-related social cues. After participants intranasally self-administered OT or placebo, they were eye-tracked while observing a nonsocial and social cues that were assigned to the in- or out-group by a minimal group paradigm. Participants under placebo did not differ in their fixation durations between stimuli, whereas participants administered OT increased gaze durations toward social but not nonsocial stimuli. In this early stage of processing, no in-group bias occurred: in-group- and out-group-related social cues were fixated equally long. These findings support that OT works by a simple illumination of social cues that seem to be processed regardless of social identity aspects at early stages of attention.


Assuntos
Atenção/efeitos dos fármacos , Sinais (Psicologia) , Ocitocina/farmacologia , Meio Social , Administração Intranasal , Adulto , Método Duplo-Cego , Inteligência Emocional/efeitos dos fármacos , Feminino , Humanos , Masculino , Ocitocina/administração & dosagem , Grupo Associado , Estimulação Luminosa , Placebos , Adulto Jovem
10.
J Neuroendocrinol ; 29(3)2017 03.
Artigo em Inglês | MEDLINE | ID: mdl-28140486

RESUMO

Altered social-emotional functioning is considered to play an important role in the development and maintenance of anorexia nervosa (AN). Recently, there has been increasing interest in investigating the role of intranasal oxytocin in social-emotional processing. The present study aimed to investigate the effects of intranasal oxytocin on the interpretation and expression of emotions among people with AN. Thirty women with AN and 29 age-matched healthy women took part in the present study, which used a double-blind, placebo-controlled, cross-over design. The participants received a single dose of 40 IU of intranasal oxytocin in one session and a placebo spray in the other. Fifteen minutes after administration, the participants completed the Reading the Mind in the Eyes Test to assess the interpretation of complex emotions and mental states followed by a video task, which assessed expressions of facial affect when they were viewing humorous and sad film clips. The intranasal oxytocin did not significantly influence the expression or interpretation of emotions in the AN or healthy comparison groups. The AN group expressed significantly less positive emotion, spent more time looking away and reported experiencing a significantly more negative affect in response to the film clips. The finding that intranasal oxytocin had little to no effect on the interpretation or expression of emotions in either group supports the notion that the effects of oxytocin on social-emotional processing are not straightforward and may depend on individual and environmental differences, as well as the emotion being processed. Replication of these findings is necessary to explore the effect of timing on the effects of oxytocin before firm conclusions can be drawn. Nonetheless, these findings add to the steady accumulation of evidence that people with AN have reduced emotional expression and avoidance of emotionally provoking stimuli.


Assuntos
Anorexia Nervosa/psicologia , Inteligência Emocional/efeitos dos fármacos , Emoções/efeitos dos fármacos , Ocitocina/administração & dosagem , Administração Intranasal , Adolescente , Adulto , Afeto/efeitos dos fármacos , Idoso , Anorexia Nervosa/tratamento farmacológico , Estudos Cross-Over , Método Duplo-Cego , Feminino , Humanos , Pessoa de Meia-Idade , Placebos , Adulto Jovem
11.
Cogn Affect Behav Neurosci ; 17(2): 437-451, 2017 04.
Artigo em Inglês | MEDLINE | ID: mdl-28032303

RESUMO

Psychosocial well-being requires effective regulation of emotional responding in context of threat or stress. Neuroimaging studies have focused on instructed, volitional regulation (e.g., reappraisal or distancing), largely ignoring implicit regulation that does not involve purposeful effort to alter emotional experience. These implicit processes may or may not involve the same neural pathways as explicit regulatory strategies. We examined the neurobiology of implicit emotional regulation processes and the impact of the stress hormone cortisol on these processes. Our study task employed composite pictures of faces and places to examine neural activity during implicit emotional processing (of emotional faces), while these responses were implicitly regulated by attention shift away from the emotionally evocative stimuli, and while subjects reflectively appraised their own emotional response to them. Subjects completed the task in an fMRI scanner after random assignment to receive placebo or hydrocortisone (HCT), an orally administered version of cortisol. Implicit emotional processing activated insula/IFG, dACC/dMPFC, midbrain and amygdala. With attention shifting, we saw diminished signal in emotion generating/response regions (e.g., amygdala) and increased activations in task specific attention regions like parahippocampus. With appraisal of emotions, we observed robust activations in medial prefrontal areas, where activation is also seen in instructed reappraisal studies. We observed no main effects of HCT administration on brain, but males and females showed opposing neural effects in prefrontal areas. The data suggest that different types of emotion regulation utilize overlapping circuits, but with some strategy specific activation. Further study of the dimorphic sex response to cortisol is needed.


Assuntos
Atenção/fisiologia , Encéfalo/fisiologia , Inteligência Emocional/fisiologia , Emoções/fisiologia , Hidrocortisona/administração & dosagem , Psicotrópicos/administração & dosagem , Análise de Variância , Atenção/efeitos dos fármacos , Encéfalo/diagnóstico por imagem , Encéfalo/efeitos dos fármacos , Mapeamento Encefálico , Inteligência Emocional/efeitos dos fármacos , Emoções/efeitos dos fármacos , Função Executiva/efeitos dos fármacos , Função Executiva/fisiologia , Feminino , Humanos , Hidrocortisona/metabolismo , Imageamento por Ressonância Magnética , Masculino , Vias Neurais/diagnóstico por imagem , Vias Neurais/efeitos dos fármacos , Vias Neurais/fisiologia , Testes Neuropsicológicos , Psicotrópicos/metabolismo , Tempo de Reação , Saliva/metabolismo , Caracteres Sexuais , Percepção Visual/efeitos dos fármacos , Percepção Visual/fisiologia , Adulto Jovem
13.
Horm Behav ; 69: 59-67, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25562712

RESUMO

Turner syndrome (TS) is the result of (partial) absence of one X-chromosome. Besides short stature, gonadal dysgenesis and other physical aspects, TS women have typical psychological features. Since psychological effects of androgen exposure in childhood probably are long-lasting, we explored long-term psychological functioning after oxandrolone (Ox) therapy during childhood in adults with TS in terms of neurocognition, quality of life and social-emotional functioning. During the initial study, girls were treated with growth hormone (GH) combined with placebo (Pl), Ox 0.03 mg/kg/day, or Ox 0.06 mg/kg/day from the age of eight, and estrogen from the age of twelve. Sixty-eight women participated in the current double-blinded follow-up study (mean age 24.0 years, mean time since stopping GH/Ox 8.7 years). We found no effects on neurocognition. Concerning quality of life women treated with Ox had higher anxiety levels (STAI 37.4 ± 8.4 vs 31.8 ± 5.0, p=0.002) and higher scores on the depression subscale of the SCL-90-R (25.7 ± 10.7 vs 20.5 ± 4.7, p=0.01). Regarding social-emotional functioning, emotion perception for fearful faces was lower in the Ox-treated patients, without effect on interpersonal behavior. Our exploratory study is the first to suggest that androgen treatment in adolescence possibly has long-term effects on adult quality of life and social-emotional functioning. However, differences are small and clinical implications of our results seem limited. Therefore we would not recommend against the use of Ox in light of psychological consequences.


Assuntos
Cognição/efeitos dos fármacos , Inteligência Emocional/efeitos dos fármacos , Emoções/efeitos dos fármacos , Oxandrolona/farmacologia , Qualidade de Vida , Síndrome de Turner/tratamento farmacológico , Adolescente , Adulto , Androgênios/administração & dosagem , Depressão/tratamento farmacológico , Depressão/psicologia , Estrogênios/administração & dosagem , Feminino , Seguimentos , Hormônio do Crescimento/uso terapêutico , Hormônio do Crescimento Humano/administração & dosagem , Humanos , Oxandrolona/administração & dosagem , Qualidade de Vida/psicologia , Fatores de Tempo , Síndrome de Turner/psicologia , Adulto Jovem
14.
Hum Psychopharmacol ; 29(6): 589-98, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25363303

RESUMO

OBJECTIVE: As sex differences in substance dependence may impinge upon the perception and regulation of emotion, we assess emotional intelligence (EI) as a function of gender, menstrual cycle (MC) phase and hormonal changes in early abstinent cocaine-dependent individuals who abuse alcohol (CDA). METHODS: Study 1: The Mayer, Salovey, and Caruso Emotional Intelligence Test (MSCEIT) was administered to 98 CDA (55 M/43 F) and 56 healthy (28 M/28 F) individuals. Performance in women was also assessed by MC phase. Study 2: The MSCEIT was administered to 28 CDA (19 M/9 F) who received exogenous progesterone (400 mg/day) versus placebo for 7 days (study 2). RESULTS: Study 1: Healthy females were better than healthy males at facilitating thought and managing emotions. This gender discrepancy was not observed in the CDA group. Additionally, all women in the high compared with the low progesterone phase of their MC were better at managing their emotions. Study 2: Exogenous progesterone improved ability to facilitate thought in both males and females. CONCLUSIONS: CDA women may be vulnerable to difficulties managing and regulating emotions. Gonadal hormones may contribute to this gender effect, as increases in both endogenous and exogenous progesterone improved selective aspects of EI.


Assuntos
Alcoolismo/complicações , Alcoolismo/fisiopatologia , Transtornos Relacionados ao Uso de Cocaína/complicações , Transtornos Relacionados ao Uso de Cocaína/fisiopatologia , Inteligência Emocional/fisiologia , Progesterona/metabolismo , Adulto , Alcoolismo/tratamento farmacológico , Alcoolismo/psicologia , Transtornos Relacionados ao Uso de Cocaína/tratamento farmacológico , Transtornos Relacionados ao Uso de Cocaína/psicologia , Inteligência Emocional/efeitos dos fármacos , Emoções/efeitos dos fármacos , Emoções/fisiologia , Feminino , Humanos , Masculino , Ciclo Menstrual/fisiologia , Ciclo Menstrual/psicologia , Progesterona/administração & dosagem , Progesterona/efeitos adversos , Testes Psicológicos , Psicotrópicos/administração & dosagem , Psicotrópicos/efeitos adversos , Caracteres Sexuais
15.
Z Kinder Jugendpsychiatr Psychother ; 42(3): 167-76, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24846865

RESUMO

OBJECTIVES: Although clear advances have been achieved in the study of early-onset schizophrenia (EOS), little is known to date about premorbid and prodromal neuropsychological functioning in EOS. METHOD: Here, we report on a case of an adolescent male with EOS who underwent neuropsychological testing before and after illness onset. RESULTS: Marked cognitive deficits in the domains of attention, set-shifting, and verbal memory were present both pre-onset and during the course of schizophrenia, though only deficits in verbal memory persisted after illness-onset and antipsychotic treatment. CONCLUSION: The findings of this case study suggest that impairments in the verbal memory domain are particularly prominent symptoms of cognitive impairment in prodromal EOS and persist in the course of the disorder, which further demonstrates the difficult clinical situation of adequate schooling opportunities for adolescent patients with EOS.


Assuntos
Testes Neuropsicológicos/estatística & dados numéricos , Esquizofrenia Paranoide/diagnóstico , Esquizofrenia Paranoide/psicologia , Transtorno da Personalidade Esquizotípica/diagnóstico , Transtorno da Personalidade Esquizotípica/psicologia , Adolescente , Antipsicóticos/uso terapêutico , Atenção/efeitos dos fármacos , Criança , Comorbidade , Deficiências do Desenvolvimento/diagnóstico , Deficiências do Desenvolvimento/psicologia , Inteligência Emocional/efeitos dos fármacos , Função Executiva/efeitos dos fármacos , Humanos , Masculino , Rememoração Mental/efeitos dos fármacos , Sintomas Prodrômicos , Escalas de Graduação Psiquiátrica/estatística & dados numéricos , Psicometria/estatística & dados numéricos , Reconhecimento Psicológico/efeitos dos fármacos , Encaminhamento e Consulta , Reprodutibilidade dos Testes , Esquizofrenia Paranoide/tratamento farmacológico , Transtorno da Personalidade Esquizotípica/tratamento farmacológico , Aprendizagem Verbal/efeitos dos fármacos
16.
Eur Neuropsychopharmacol ; 24(4): 575-84, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24418213

RESUMO

To date, only few studies have examined the impact of medication on social cognition and none have examined the effects of aripiprazole in this respect. The goal of this 8-week, randomized, multicenter, open-label study was to examine the effects of aripiprazole and risperidone on social cognition and neurocognition in individuals with schizophrenia. Eighty schizophrenia patients (DSM-IV-TR) aged 16-50 years were administered multiple computerized measures of social cognition and neurocognition including reaction times at baseline and the end of week 8. Social functioning was mapped with the Social Functioning scale and Quality of Life scale. The study ran from June 2005 to March 2011. Scores on social cognitive and neurocognitive tests improved with both treatments, as did reaction time. There were few differences between the two antipsychotics on (social) cognitive test-scores. The aripiprazole group performed better (more correct items) on symbol substitution (P=.003). Aripiprazole was also superior to risperidone on reaction time for emotional working memory and working memory (P=.006 and P=.023, respectively). Improvements on these tests were correlated with social functioning. In conclusion, aripiprazole and risperidone showed a similar impact on social cognitive test-scores. However, aripiprazole treatment produced a greater effect on patients' processing speed compared to risperidone, with these improvements being associated with concurrent improvements in social functioning. Further research on the long-term effects of aripiprazole on cognition is warranted.


Assuntos
Aripiprazol/uso terapêutico , Agonistas de Dopamina/uso terapêutico , Antagonistas de Dopamina/uso terapêutico , Inteligência Emocional/efeitos dos fármacos , Risperidona/uso terapêutico , Esquizofrenia/tratamento farmacológico , Transtornos do Comportamento Social/prevenção & controle , Adolescente , Adulto , Antipsicóticos/administração & dosagem , Antipsicóticos/efeitos adversos , Antipsicóticos/uso terapêutico , Aripiprazol/administração & dosagem , Aripiprazol/efeitos adversos , Manual Diagnóstico e Estatístico de Transtornos Mentais , Agonistas de Dopamina/administração & dosagem , Agonistas de Dopamina/efeitos adversos , Antagonistas de Dopamina/administração & dosagem , Antagonistas de Dopamina/efeitos adversos , Monitoramento de Medicamentos , Feminino , Humanos , Masculino , Memória de Curto Prazo/efeitos dos fármacos , Pessoa de Meia-Idade , Países Baixos , Pacientes Desistentes do Tratamento , Tempo de Reação/efeitos dos fármacos , Reconhecimento Psicológico/efeitos dos fármacos , Risperidona/administração & dosagem , Risperidona/efeitos adversos , Esquizofrenia/fisiopatologia , Transtornos do Comportamento Social/etiologia , Adulto Jovem
17.
Emotion ; 14(1): 43-50, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24188065

RESUMO

Evidence suggests that intranasal oxytocin enhances the perception of emotion in facial expressions during standard emotion identification tasks. However, it is not clear whether this effect is desirable in people who do not show deficits in emotion perception. That is, a heightened perception of emotion in faces could lead to "oversensitivity" to the emotions of others in nonclinical participants. The goal of this study was to assess the effects of intranasal oxytocin on emotion perception using ecologically valid social and nonsocial visual tasks. Eighty-two participants (42 women) self-administered a 24 IU dose of intranasal oxytocin or a placebo in a double-blind, randomized experiment and then completed the perceiving and understanding emotion components of the Mayer-Salovey-Caruso Emotional Intelligence Test. In this test, emotion identification accuracy is based on agreement with a normative sample. As expected, participants administered intranasal oxytocin rated emotion in facial stimuli as expressing greater emotional intensity than those given a placebo. Consequently, accurate identification of emotion in faces, based on agreement with a normative sample, was impaired in the oxytocin group relative to placebo. No such effect was observed for tests using nonsocial stimuli. The results are consistent with the hypothesis that intranasal oxytocin enhances the salience of social stimuli in the environment, but not nonsocial stimuli. The present findings support a growing literature showing that the effects of intranasal oxytocin on social cognition can be negative under certain circumstances, in this case promoting "oversensitivity" to emotion in faces in healthy people.


Assuntos
Inteligência Emocional/efeitos dos fármacos , Emoções , Expressão Facial , Testes de Inteligência , Ocitocina/administração & dosagem , Ocitocina/farmacologia , Percepção/efeitos dos fármacos , Administração Intranasal , Adolescente , Adulto , Método Duplo-Cego , Inteligência Emocional/fisiologia , Feminino , Voluntários Saudáveis , Humanos , Masculino , Modelos Psicológicos , Percepção/fisiologia , Comportamento Social , Adulto Jovem
18.
Front Neuroendocrinol ; 33(2): 140-59, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22369749

RESUMO

Sociality comes with specific cognitive skills that allow the proper processing of information about others (social recognition), as well as of information originating from others (social learning). Because sociality and social interactions can also facilitate the spread of infection among individuals the ability to recognize and avoid pathogen threat is also essential. We review here various studies primarily from the rodent literature supporting estrogenic involvement in the regulation of social recognition, social learning (socially acquired food preferences and mate choice copying) and the recognition and avoidance of infected and potentially infected individuals. We consider both genomic and rapid estrogenic effects involving estrogen receptors α and ß, and G-protein coupled estrogen receptor 1, along with their interactions with neuropeptide systems in the processing of social stimuli and the regulation and expression of these various socially relevant behaviors.


Assuntos
Aprendizagem da Esquiva/efeitos dos fármacos , Inteligência Emocional/efeitos dos fármacos , Estrogênios/farmacologia , Infecções/psicologia , Aprendizagem/efeitos dos fármacos , Reconhecimento Psicológico/efeitos dos fármacos , Animais , Aprendizagem da Esquiva/fisiologia , Estrogênios/fisiologia , Humanos , Aprendizagem/fisiologia , Camundongos , Modelos Biológicos , Reconhecimento Psicológico/fisiologia , Comportamento Social
19.
Psychol Addict Behav ; 26(2): 201-11, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21875167

RESUMO

The present investigation determined how different component-processes of executive functioning (EF) served as risk factors for intoxicated aggression. Participants were 512 (246 males and 266 females) healthy social drinkers between 21 and 35 years of age. EF was measured using the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) that assesses nine EF components. After the consumption of either an alcohol or a placebo beverage, participants were tested on a modified version of the Taylor Aggression Paradigm in which mild electric shocks were received from, and administered to, a fictitious opponent. Aggressive behavior was operationalized as the shock intensities and durations administered to the opponent. Although a general BRIEF-A EF construct consisting of all nine components predicted intoxicated aggression, the best predictor involved one termed the Behavioral Regulation Index that comprises component processes such as inhibition, emotional control, flexible thinking, and self-monitoring.


Assuntos
Agressão/efeitos dos fármacos , Intoxicação Alcoólica/psicologia , Função Executiva/efeitos dos fármacos , Inventário de Personalidade/estatística & dados numéricos , Adulto , Agressão/psicologia , Intoxicação Alcoólica/fisiopatologia , Testes Respiratórios , Estimulação Elétrica , Inteligência Emocional/efeitos dos fármacos , Etanol/administração & dosagem , Etanol/análise , Função Executiva/fisiologia , Feminino , Humanos , Inibição Psicológica , Masculino , Placebos , Análise de Regressão , Fatores de Risco , Autorrelato , Autoavaliação (Psicologia) , Adulto Jovem
20.
Am J Addict ; 20(2): 151-60, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21314758

RESUMO

Emotional Intelligence (EI) comprises the ability to perceive, use, understand, and regulate emotions and may potentially contribute to variability in risk-related factors such as stress perception and impulse control in cocaine dependent individuals. The main objective of the current study is to better define EI in cocaine dependent individuals compared with healthy controls, using the Mayer, Salovey, and Caruso Emotional Intelligence Test (MSCEIT). Secondary analysis investigates the association between EI, IQ factors, perceived stress, and impulse control in both populations. Seventy-two abstinent treatment-seeking cocaine patients and 52 healthy controls were administered the MSCEIT as well as measures of IQ, perceived stress, and impulse control. Findings showed that cocaine dependent participants demonstrated highly selective EI difficulties compared with healthy controls, specifically with regard to higher-level emotional reasoning including the understanding, management, and regulation of emotion. These EI problems were associated with increased perceived stress and impulse control difficulties. IQ was significantly associated with all MSCEIT measures in the cocaine dependent participants, but not controls. Findings indicate that specific aspects of EI may be of clinical importance to cocaine dependent populations, impacting relapse-related factors such as stress dysregulation and impulse control.


Assuntos
Transtornos Relacionados ao Uso de Cocaína/psicologia , Transtornos Disruptivos, de Controle do Impulso e da Conduta/psicologia , Inteligência Emocional/efeitos dos fármacos , Estresse Psicológico/psicologia , Adolescente , Adulto , Estudos de Casos e Controles , Transtornos Relacionados ao Uso de Cocaína/complicações , Transtornos Disruptivos, de Controle do Impulso e da Conduta/complicações , Humanos , Testes de Inteligência , Masculino , Pessoa de Meia-Idade , Estresse Psicológico/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA